FDA发布有关生物类似物许可和标签以及某些补充申请审...
2020.02.07
FDA Issues Draft Guidance on Biosimilar Licensing and Labeling, Timing of Certain Supplement Reviews
The following quote is attributed to Sarah Yim, M.D., director of the Office of Therapeutic Biologics and Biosimilars in the FDA’s Center for Dru...
|